Working... Menu
Trial record 2 of 125 for:    lapatinib | Recruiting, Active, not recruiting, Completed Studies | Phase 2

Safety and Clinical Activity of Lapatinib in Patients With HER2-positive Refractory Advanced Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02342587
Recruitment Status : Completed
First Posted : January 21, 2015
Last Update Posted : February 17, 2017
Information provided by (Responsible Party):
Jeeyun Lee, Samsung Medical Center

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : January 2016
  Actual Study Completion Date : August 21, 2016